Chordia’s pipeline is built on expertise in RNA deregulation; a newly proposed cancer hallmark whose therapeutic potential is relatively unexplored (Fig. 1). Recent research has shown that RNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback